Spectral to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

Author's Avatar
May 13, 2022

TORONTO, ON / ACCESSWIRE / May 13, 2022 / Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT, Financial), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. ("Dialco"), today announced that Chris Seto, CEO and Dr. Jon Kellum, CMO of Spectral Medical, have been invited to present at the Spring Into Action - Best Ideas Investor Conference, which is being held virtually May 16th-20th, 2022.